What Is GHK-Cu? Copper Peptide Research

What Is GHK-Cu? The Copper Peptide and Its Published Research

GHK-Cu is a complex of copper(II) and the tripeptide glycyl-L-histidyl-L-lysine (GHK). It occurs naturally in human plasma, where Loren Pickart first isolated the peptide in 1973. Since then, researchers have studied GHK-Cu mostly in cell culture, in tissue models, and through large gene-expression datasets.

GHK-Cu at a glance

Why a tripeptide grabs copper so tightly

GHK on its own is a very small molecule. What makes it interesting is how strongly it binds copper(II): the histidine side chain, the glycine amino group and the backbone nitrogen form a tight complex with the metal ion. That makes GHK-Cu a textbook example of a metallopeptide. It's also why the literature treats GHK and GHK-Cu as closely linked but not interchangeable, and why papers often specify which form they used.

For your own work, this distinction is easy to overlook. If a paper reports results with "GHK," check the methods to see whether copper was added or whether the authors relied on copper already present in the medium. It changes how you compare results across studies. (We wrote a separate guide on keeping GHK, CuGHK and modified systems apart when you read papers.)

The origin story: a plasma factor and an aging question

Pickart's original observation came from comparing plasma from younger and older donors on incubated slices of human liver tissue. Plasma from younger donors shifted how the older liver tissue behaved, and the activity was traced to a small tripeptide. He and M. M. Thaler published the finding in Nature New Biology in 1973 (source). The sequence, glycyl-histidyl-lysine, followed in a 1977 paper (source), and Pickart's later reviews describe the decades of follow-up work (source).

That history explains why so much GHK-Cu writing focuses on regeneration and repair. It also explains a bias in the literature, which we get to further down.

What the published research reports

Collagen synthesis in fibroblast cultures (1988)

This is probably the most-cited early experimental paper, and it came from François-Xavier Maquart's group in Reims, independent of Pickart. Maquart and colleagues added GHK-Cu to fibroblast cultures and measured collagen production. They reported that it stimulated collagen synthesis, and that the effect didn't come from an increase in cell number (source).

One detail from that paper stuck with us. The authors pointed out that the GHK sequence appears inside the α2(I) chain of type I collagen itself. Their hypothesis: when proteases break down collagen at a damaged site, they could release GHK locally, which would then signal for new matrix. It's an elegant idea. As far as we can tell, it remains a hypothesis rather than something that's been directly demonstrated.

The same group followed up in 1993 with experimental wounds in rats. They reported higher mRNA levels for type I and type III collagen but no change in TGF-β mRNA, and a control tripeptide had no significant effect (source).

Elastin and collagen in dermal fibroblasts

Pickart and Margolina's 2018 review summarizes later in vitro work in which GHK-Cu incubated with adult human dermal fibroblasts increased elastin and collagen production. The same review covers effects on matrix metalloproteinases and their inhibitors, the enzymes that remodel the extracellular matrix (source).

The emphysema gene signature (2012)

This is the study we'd point a new researcher to first. It also comes from outside Pickart's circle.

Joshua Campbell and colleagues at Boston University profiled gene expression in lung tissue from people with COPD and identified a signature associated with emphysematous tissue destruction. They then searched the Broad Institute's Connectivity Map, a database of gene-expression changes caused by thousands of compounds, for anything that pushed expression in the opposite direction. GHK came up.

In follow-up cell experiments, adding GHK to fibroblasts derived from COPD lung tissue restored their ability to contract and remodel collagen gels, in a way similar to TGF-β (source). The work stayed at the cell-culture level; an accompanying commentary noted that animal studies would be needed to show anything in vivo.

Large-scale gene-expression data

Pickart's later reviews mine the same Connectivity Map data more broadly. They report that GHK shifts the expression of a large share of human genes, with more genes up-regulated than suppressed (source). These numbers get repeated a lot online, usually without the caveat the authors themselves attach (see below).

Limitations to keep in mind

One dominant review author. A large part of the GHK-Cu review literature is written by Pickart, who discovered the peptide and in 1985 founded ProCyte Corporation to commercialize copper-peptide technology (source). That doesn't invalidate the work. It does mean you should read the disclosures and weigh independent studies, like the Maquart papers and the 2012 Genome Medicine study, more heavily when you can.

Gene expression isn't function. The Connectivity Map findings describe changes in mRNA in specific cell lines under specific conditions. The 2018 review itself acknowledges that there isn't enough information yet to link those expression changes to actual biological activity. Treat gene counts as a starting point for hypotheses (our explainer on transcriptomics vs proteomics covers why).

Mostly in vitro. The best-characterized findings come from fibroblast cultures. Results in a dish often don't carry over to whole organisms, and in vivo data on GHK-Cu remain limited. See in vitro vs clinical studies for how those evidence types differ.

Form matters. GHK, GHK-Cu and other GHK salts aren't always reported clearly. Mixing them up makes cross-study comparisons unreliable.

Frequently asked questions

Is GHK-Cu the same as GHK?

No. GHK is the free tripeptide (Gly-His-Lys). GHK-Cu is that peptide bound to a copper(II) ion. They're closely related, and GHK binds copper readily, but published studies don't always use them interchangeably.

Is GHK-Cu naturally occurring?

Yes. The GHK peptide was first isolated from human plasma, and it's been reported in saliva and urine as well. The GHK sequence also appears within the type I collagen chain.

What models has GHK-Cu been studied in?

Mainly cultured fibroblasts and other cell lines, tissue models, and computational analyses of gene-expression databases such as the Connectivity Map. Maquart's fibroblast and rat-wound studies and the 2012 emphysema study are the main examples of work from outside Pickart's group.

Sourcing GHK-Cu for research

If you're setting up experiments, you can find GHK-Cu in our catalog along with the rest of our research compounds. Every product we sell is for laboratory research use only. It isn't intended for human or veterinary use, and nothing in this article is a recommendation to use it that way.